NYSE: JACS
Jackson Acquisition Co II Stock

$10.30+0.00 (+0%)
Updated Jun 13, 2025
JACS Price
$10.30
Fair Value Price
N/A
Market Cap
$304.78M
52 Week Low
$9.94
52 Week High
$10.41
P/E
N/A
P/B
522.29x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
403.91
Operating Cash Flow
N/A
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine JACS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Shell Company

Industry Rating
F
JACS
Ranked
Unranked of 40

Top Ranked Stocks in Industry

View Top Shell Company Stocks

Be the first to know about important JACS news, forecast changes, insider trades & much more!

JACS News

Overview

Due Diligence Score

Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how JACS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

JACS is good value based on its book value relative to its share price (522.29x), compared to the US Shell Companies industry average (-59.45x)
P/B vs Industry Valuation
JACS's short-term assets ($927.90k) exceed its short-term liabilities ($405.16k)
Short-term Liabilities Financials
JACS's long-term liabilities ($235.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more JACS due diligence checks available for Premium users.

Valuation

JACS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
15.6x
Market
31.36x

JACS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
522.29x
Industry
-59.45x
JACS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

JACS's financial health

Profit margin

Revenue
$0.0
Net Income
$2.2M
Profit Margin
0%

Assets to liabilities

Assets
$236.3M
Liabilities
$235.7M
Debt to equity
403.91
JACS's short-term assets ($927.90k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
JACS's long-term liabilities ($235.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
JACS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$193.4k
Investing
$0.0
Financing
$0.0

JACS vs Shell Company Stocks

TickerZen RatingMarket Cap1d %P/EP/B
JACS$304.78M0.00%N/A522.29x
VCIC$304.01M0.00%N/A-39.14x
POLE$306.31M0.00%N/A-33.90x
LOKVC$303.03M+0.57%N/A-26.61x
TVAC$302.40M+0.20%N/A-5,096.66x

Jackson Acquisition Co II Stock FAQ

What is Jackson Acquisition Co II's quote symbol?

(NYSE: JACS) Jackson Acquisition Co II trades on the NYSE under the ticker symbol JACS. Jackson Acquisition Co II stock quotes can also be displayed as NYSE: JACS.

If you're new to stock investing, here's how to buy Jackson Acquisition Co II stock.

What is the 52 week high and low for Jackson Acquisition Co II (NYSE: JACS)?

(NYSE: JACS) Jackson Acquisition Co II's 52-week high was $10.41, and its 52-week low was $9.94. It is currently -1.06% from its 52-week high and 3.62% from its 52-week low.

How much is Jackson Acquisition Co II's stock price per share?

(NYSE: JACS) Jackson Acquisition Co II stock price per share is $10.30 today (as of Jun 13, 2025).

What is Jackson Acquisition Co II's Market Cap?

(NYSE: JACS) Jackson Acquisition Co II's market cap is $304.78M, as of Jun 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Jackson Acquisition Co II's market cap is calculated by multiplying JACS's current stock price of $10.30 by JACS's total outstanding shares of 29,590,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.